Concord Wealth Partners Lemaitre Vascular Inc Transaction History
Concord Wealth Partners
- $673 Million
- Q2 2025
A detailed history of Concord Wealth Partners transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Concord Wealth Partners holds 69 shares of LMAT stock, worth $6,503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 59
16.95%
Holding current value
$6,503
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LMAT
# of Institutions
294Shares Held
21MCall Options Held
300Put Options Held
400-
Black Rock Inc. New York, NY3.48MShares$328 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.6MShares$151 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$149 Million0.0% of portfolio
-
Copeland Capital Management, LLC990KShares$93.3 Million1.74% of portfolio
-
Geneva Capital Management LLC915KShares$86.3 Million1.3% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $2.07B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...